Quantitative evaluation of the IL-1β and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 14, Issue 1, 1997, Pages 39-45

  Mikuniya, Takeshi ^a   Nagai, Sonoko ^a   Shimoji, Tsutomu ^b   Takeuchi, Minoru ^c   Morita, Koji ^a   Mio, Tadashi ^a   Satake, Norio ^a   Izumi, Takateru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c KYOTO SANGYO UNIVERSITY   (Japan)

Author keywords

Chronic smoking; Gene transcripts; Idiopathic pulmonary fibrosis; IL 1 and IL 1 receptor antagonist; Immunoreactive amounts of protein; Pulmonary sarcoidosis

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA PRIMERS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; JAPAN; LUNG DISEASES, INTERSTITIAL; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PULMONARY FIBROSIS; SARCOIDOSIS, PULMONARY; SIALOGLYCOPROTEINS; SMOKING; TRANSCRIPTION, GENETIC;

EID: 0030974588     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Winterbauer RH, Hammer SP: Sarcoidosis and idiopathic pulmonary fibrosis; a review of recent events. Cur Pulmonol 1986; 7:117-164.
2. Nagai S, Satake N, Shimoji T et al: Bronchoalveolar lavage (BAL) findings in patients with idiopathic pulmonary fibrosis (IPF). In: Takishima T, (Ed.) Basic and Clinical Aspects of Pulmonary Fibrosis. CRC Press, Inc. 1994: pp 325-339.
3. Nagai S, Kitaichi M, Nishimura K, Izumi T: Clinical profiles and prognosis of 337 cases with pulmonary sarcoidosis who were observed for more than ten years. Am J Respir Crit Care Med 1995; 151:A549.
4. Kelley J: Cytokines of the lung. Am Rev Respir Dis 1990; 141: 765-788.
5. Di Giovine FS, Duff GW: Interleukin 1: the first interleukin. Immunol Today 1990; 11: 13-20.
6. Lohmann-Matthes M-L, Steinmuller C, Franke-Ullmann G: Pulmonary macrophages. Eur Respir J 1994; 7: 1678-1689.
7. Charles AD: Interleukin-1 and interleukin-1 antagonist. Blood 1991; 77-8: 1627-1652.
8. Nagai S, Takeuchi M, Watanabe et al: Smoking and interleukin-1 activity released from human alveolar macrophages in healthy subjects. Chest 1988; 94: 694-700.
9. Nagai S, Hting A, Takeuchi M et al: IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases. Chest 1991; 99: 674-680.
10. Eisenberg SP, Evans RJ, Arend WP et al: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990; 343: 341-346.
11. Takeuchi M, Nagai S, Nakada H et al: Characterization of IL-1 inhibitory factor released from human alveolar macrophages as IL-1 receptor antagonist. Clin Exp Immunol 1992; 88: 181-187.
12. Izumi T: Sarcoidosis. In: RC Bone (Ed.). Pulmonary and Clinical Care Medicine, vol. 2. St. Louis: Mosby Year Book, 1993;pp. 1-9.
13. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocynate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
14. Carre PC, Mortenson RL, King TE et al: Increased expression of the interleukin 8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J Clin Invest 1991; 88: 1802-1810.
15. Schmitt JF, Guthridge M, Economou C et al: A new quantitative polymerase chain reaction high liquid chromatographic methods for detection of fibroblast growth factor-ß (FGF-ß) gene amplification. J Biochem Biophys Methods 1992; 24: 119-133.
16. Müller Quernheim J, Pfeifer S, Mannel D et al: Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992; 145: 187-192.
17. Sone S, Orino E, Mizuno M et al: Production of IL-1 and its receptor antagonist is regulated differently by IFN-γ and IL-4 in human monocytes and alveolar macrophages. Eur Respir J 1994; 7: 657-663.
18. Hunninghake GW, Garrett KC, Richerson HB et al: Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis 1984; 130: 476-496.
19. Kovas EJ: Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12:17-23.
20. Takeuchi M, Nagai S, Nakada H et al: No increase in the expression of interleukin-1 receptor on lung fibroblasts in idiopathic pulmonary fibrosis (IPF). Am Rev Respir Dis 1993: 147-7; A592.
21. Boraschi D, Rambaldi A, Sica A et al: Endothelial cells express the interleukin-1 receptor type I. Blood 1991: 78-5; 1262-1267.
22. Bonin PD, Singh JP: Modulation of interleukin-1 receptor expression and interleukin-1 response in fibroblast by platelet-derived growth factor. J Biol Chem 1988: 263; 11052-11055.
23. Du Bois RM, Ruscetti FW, Palaszynski EW et al: Transforming growth factor ß is a potent inhibitor of interleukin-1 (IL-1) receptor expression: Proposed mechanism of inhibition of IL-1 action. J Exp Med 1990: 172; 737-744.